Growing community of inventors

Pittsburgh, PA, United States of America

David J Hackam

Average Co-Inventor Count = 1.88

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 87

David J HackamPeter Wipf (6 patents)David J HackamMatthew D Neal (4 patents)David J HackamChhinder P Sodhi (4 patents)David J HackamSodhi P Chhinder (3 patents)David J HackamSteven C Gribar (2 patents)David J HackamJun O Liu (1 patent)David J HackamPeng Lu (1 patent)David J HackamDavid J Hackam (13 patents)Peter WipfPeter Wipf (83 patents)Matthew D NealMatthew D Neal (5 patents)Chhinder P SodhiChhinder P Sodhi (4 patents)Sodhi P ChhinderSodhi P Chhinder (3 patents)Steven C GribarSteven C Gribar (2 patents)Jun O LiuJun O Liu (26 patents)Peng LuPeng Lu (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Pittsburgh (12 from 1,860 patents)

2. Johns Hopkins University (3 from 3,682 patents)


13 patents:

1. 11458141 - Aryl hydrocarbon receptor (AhR) agonists for the prevention and treatment of inflammatory disorders

2. 11413299 - Compositions and methods for treatment of inflammatory disorders

3. 10933077 - TLR4 inhibitors for the treatment of human infectious and inflammatory disorders

4. 10668092 - Compositions and methods for treatment of inflammatory disorders

5. 10300083 - TLR4 inhibitors for the treatment of human infectious and inflammatory disorders

6. 10172848 - Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease

7. 9562066 - Oral therapy of necrotizing enterocolitis

8. 9549980 - Methods of treating necrotizing enterocolitis by administering nuclear oligomerization domain-2 agonists,TLR9 agonists and TLR4 antagonists

9. 9532999 - TLR4 inhibitors for the treatment of human infectious and inflammatory disorders

10. 9072760 - TLR4 inhibitors for the treatment of human infectious and inflammatory disorders

11. 8518903 - Use of toll-like receptor-9 agonists

12. 8518905 - Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment of prevention of toll-like receptor-4-associated disorders

13. 8188058 - Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…